The potential use of antibacterial peptide antibody indices in the diagnosis of rheumatoid arthritis and ankylosing spondylitis.

BACKGROUND: Both rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are potentially disabling arthritic disorders for which as yet no highly sensitive and reliable diagnostic laboratory markers are available. OBJECTIVE: The objective of this study was to evaluate the levels of antibodies agai...

Descripción completa

Detalles Bibliográficos
Publicado en:JRC: Journal of Clinical Rheumatology Vol. 12; no. 1; pp. 11 - 17
Autores principales: Rashid T, Ebringer A, Wilson C, Bansal S, Paimela L, Binder A
Formato: equations & formulas research tables/charts Journal Article
Publicado: Lippincott Williams & Wilkins Feb2006
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106432854&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106432854
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10761608
        N16
      jtl: JRC: Journal of Clinical Rheumatology
      issn: 10761608
      maglogo: N
    pubinfo:
      dt: Feb2006
      vid: 12
      iid: 1
      pid: 433
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        106432854
        106432854
        2009151973
        10.1097/01.rhu.0000200374.14619.f2
        NLM16484874
        106432854
      ppf: 11
      ppct: 6
      formats:
      tig:
        atl: The potential use of antibacterial peptide antibody indices in the diagnosis of rheumatoid arthritis and ankylosing spondylitis.
      aug:
        au:
          Rashid T
          Ebringer A
          Wilson C
          Bansal S
          Paimela L
          Binder A
        affil: Division of Health and Life Sciences, King's College London, UK
      sug:
        subj:
          Antibodies Diagnostic Use
          Arthritis, Rheumatoid Diagnosis
          Spondylitis, Ankylosing Diagnosis
          Adult
          Aged
          Confidence Intervals
          Enzyme-Linked Immunosorbent Assay
          Female
          Male
          Middle Age
          Sensitivity and Specificity
          T-Tests
          United Kingdom
          Funding Source
          Human
          Adult: 19-44 years
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
          Male
      ab: BACKGROUND: Both rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are potentially disabling arthritic disorders for which as yet no highly sensitive and reliable diagnostic laboratory markers are available. OBJECTIVE: The objective of this study was to evaluate the levels of antibodies against Proteus and Klebsiella antigenic peptides in an endeavor to develop diagnostic indices for the identification of patients with RA and AS, respectively. METHODS: Sera from 50 patients with RA, 34 patients with AS, and 38 healthy subjects were screened for antibodies against 'ESRRAL' and 'IRRET' synthetic amino acid peptides obtained from Proteus hemolysin and urease (HU) as well as against 'QTDRED' and 'DRDE' peptides from Klebsiella nitrogenase and pullulanase (NP) proteins, respectively. Multiplication of the 2 antibodies against each organism produced indices for RA-HU and AS-NP. RESULTS: Significantly increased levels of anti-HU antibodies (P<0.0001) were observed in patients with RA when compared with patients with AS or with healthy control subjects. Patients with AS were found to have significantly elevated levels of anti-NP (P<0.0001) antibodies when compared with patients with RA or with healthy subjects. Furthermore, all patients with RA were found to have values of anti-HU antibody (RA-HU) index above 95% confidence limit (CL) of the mean of healthy control subjects; meanwhile, all patients with AS were having values of anti-NP antibody (AS-NP) index above the 95% CL of the mean of healthy control subjects (100% sensitivity). However, the specificity of the RA-HU index in RA and the AS-NP index in patients with AS were 92% and 95%, respectively. CONCLUSION: The use of the RA-HU or AS-NP diagnostic index as a sole marker or in combination with other autoantibody markers could be used in the identification of patients with RA or AS, respectively. Longitudinal investigations starting with patients with early disease will be needed.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N